Sign In
Buy DBVT
$13.63
-0.230 (-1.66%)
At Close: Jul 24, 2026
DBV Technologies to Participate in Upcoming March Investor Conferences
04:30pm, Wednesday, 04'th Mar 2026
Châtillon, France, March 4, 2026 DBV Technologies to Participate in Upcoming March Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a late-s
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
02:25pm, Saturday, 28'th Feb 2026
Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting Approximately 83% of children treated with the
Châtillon, France, February 10, 2026 DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in
DBV Technologies S.A. (NASDAQ:DBVT) Receives Consensus Rating of “Moderate Buy” from Brokerages
04:46am, Saturday, 07'th Feb 2026
Shares of DBV Technologies S.A. (NASDAQ: DBVT - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the ten brokerages that are presently covering the firm, MarketBeat rep
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
04:30pm, Thursday, 05'th Feb 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing T
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
04:00pm, Monday, 12'th Jan 2026
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
04:00pm, Monday, 05'th Jan 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
DBV Technologies (NASDAQ:DBVT) Shares Gap Down on Insider Selling
01:16am, Tuesday, 23'rd Dec 2025
Shares of DBV Technologies S.A. (NASDAQ: DBVT - Get Free Report) gapped down before the market opened on Monday following insider selling activity. The stock had previously closed at $22.76, but opene
First Look: Gold hits records, Jim Beam pause, Apple fined
07:37am, Monday, 22'nd Dec 2025
Stock News Gold and silver set new records: Spot gold and silver surged to fresh allâtime highs on haven demand and rateâcut bets, with iShares MSCI Global
Bpifrance Epic Sells 1,292,103 Shares of DBV Technologies (NASDAQ:DBVT) Stock
04:02am, Sunday, 21'st Dec 2025
DBV Technologies S.A. (NASDAQ: DBVT - Get Free Report) major shareholder Bpifrance Epic sold 1,292,103 shares of DBV Technologies stock in a transaction dated Thursday, December 18th. The shares were
Bpifrance Epic Sells 2,076,990 Shares of DBV Technologies (NASDAQ:DBVT) Stock
04:02am, Sunday, 21'st Dec 2025
DBV Technologies S.A. (NASDAQ: DBVT - Get Free Report) major shareholder Bpifrance Epic sold 2,076,990 shares of the company's stock in a transaction on Wednesday, December 17th. The stock was sold at
Peanut Allergy Patch For Kids? DBV Technologies Advances Toward FDA Filing
08:49am, Wednesday, 17'th Dec 2025
DBV Technologies S.A. (NASDAQ: DBVT) on Tuesday released data from the VITESSE Phase 3 study assessing the safety and efficacy of VIASKIN Peanut patch for peanut-allergic children aged 4 to 7 years.
DBV Technologies S.A. (DBVT) Discusses Positive Phase III VITESSE Trial Results for Peanut Allergy Patch in Young Children Transcript
Pre-Market Stock Futures: Futures are trading higher on Monday as we head into the final trading weeks of 2025. All of the major indices were hit hard on Friday as investors began a big rotation last
